Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections
Explore this paper's citation graph
Summary
The inhalation of phages as antibacterial treatment seems both clinically relevant and technically feasible and several crucial points still need to be investigated, such as phage product pharmacokinetics and immunogenicity.
- Type
- review
- Published
- 2017-08-01
- Cited by
- 46
- References
- 97
- Access
- Open access
- OpenAlex
- https://openalex.org/W2534840182
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31372808
Keywords
Phage therapy, Context (archaeology), Intensive care medicine, Biopharmaceutical, Medicine
References
- Phage as a modulator of immune responses: practical implications for phage therapy.
- Therapeutic effect of the YH6 phage in a murine hemorrhagic pneumonia model.
- In vitro lung delivery of bacteriophages KS4‐M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis
- Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy
- Withholding antibiotic treatment in pneumonia patients with dementia: a quantitative observational study.
- Pneumonia Before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America
- Bacteriophage applications: where are we now?
- Phage therapy of pulmonary infections
- Mammalian Host-Versus-Phage immune response determines phage fate in vivo
- Experimental phage therapy against lethal lung-derived septicemia caused by Staphylococcus aureus in mice.
- Toward Modern Inhalational Bacteriophage Therapy: Nebulization of Bacteriophages of Burkholderia cepacia Complex
- Coevolution of bacteria and their viruses
- Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages*
- Decreasing Enterobacter sakazakii (Cronobacter spp.) food contamination level with bacteriophages: prospects and problems
- The next generation of bacteriophage therapy.
- Evaluation of the Efficacy of a Bacteriophage in the Treatment of Pneumonia Induced by Multidrug Resistance Klebsiella pneumoniae in Mice
- Phage treatment of human infections
- Revenge of the phages: defeating bacterial defences
- Update on the antibiotic resistance crisis.
- Protein stability in pulmonary drug delivery via nebulization.
Cited by
- The Perfect Bacteriophage for Therapeutic Applications—A Quick Guide
- Phages of life – the path to pharma
- Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period
- Phage Therapy as a New Approach in Treating Emerging Antibiotic Resistant Infections
- Inspiromatic‐safety and efficacy study of a new generation dry powder inhaler in asthmatic children
- Phage Therapy for Respiratory Infections
- Personalizing the Management of Pneumonia.
- Mycovirus therapy for invasive pulmonary aspergillosis?
- Intra-tracheal amikacin spray delivery in healthy mechanically ventilated piglets.
- Epidemiology of Streptococcus agalactiae in pregnant Western Australian women and characterisation of bacteriophage activity
- Diversity and Host Specificity Revealed by Biological Characterization and Whole Genome Sequencing of Bacteriophages Infecting Salmonella enterica
- Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies
- Drug screening of rhodanine derivatives for antibacterial activity
- How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections
- The varying effects of a range of preservatives on Myoviridae and Siphoviridae bacteriophages formulated in a semi‐solid cream preparation
- High Frequency Acoustic Nebulization for Pulmonary Delivery of Antibiotic Alternatives Against Staphylococcus aureus.
- The Stabilizing Excipients in Dry State Therapeutic Phage Formulations
- Inhaled antibiotics during mechanical ventilation—why it will work
- Encapsulation and Delivery of Therapeutic Phages
- The clinical path to deliver encapsulated phages and lysins.
Related papers
- The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development.
- The formulation and immunogenicity of therapeutic proteins: Product quality as a key factor.
- Factors involved in the immunogenicity of biopharmaceutical products and mitigation strategies
- Antibodies against Erythropoietin and Other Protein‐Based Therapeutics: An Overview
- Bacteriophage therapy.
- Research Progress in Phage Therapy of Bacterial Infections
- Bacteriophage therapy,old idea,new stage
- Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
- Bacteriophage Therapy as an Application for Bacterial Infection in China